Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: The plan, revealed by Illinois Department of Veterans' Affairs Director Erica Jeffries at a legislative hearing in Chicago, comes after a pledge by the Republican governor less than two months ago that he would replace antiquated plumbing which could provide harbor for the bacteria that causes the deadly, pneumonia-like malady. Rauner did say at the time a newly constructed facility could be a long-term option. "The cost and the disruption and the construction that would be involved, not to mention the time it would take to do this (plumbing replacement) would just not be worth the effort when you think about building a brand-new building," Jeffries said Monday. "We do not want to spend years tearing up 70-year-old buildings to put brand-new piping in when we know that might not be a total solution." Rauner stayed at the home for a week in January to dramatize his efforts to get to the bottom of the outbreak. He has been pummeled by opponents in his re-election bid who say his administration's response has mishandled the crisis. Jeffries, who did not cite a potential cost, said several of the buildings on the 130-year-old campus in western Illinois would be razed to make way for "state-of-the-art facilities" during the next three to five years. At another point Jeffries indicated that preliminary recommendations from task forces Rauner appointed would be delivered by March 31 with a final version due May 1. Rauner faces voters in a GOP primary election March 20. Rauner spokeswoman Rachel Bold said late Monday that plumbing replacement hasn't been ruled out and noted that Rauner's pronouncement in January included suggesting constructing a "brand-new building here that has the latest technology." The administration installed a $6.5 million water-treatment plant, adopted rigorous plumbing-fixture flushing protocols, installed filters on fixtures, and treated water with heat and chemicals, among other steps, in its effort to stop the problem. After initially appearing in 2015, Legionnaire's disease returned to the facility in 2016 and 2017. Four more cases were confirmed last month. Monday's hearing was called after the administration released an August 2016 report from Belleville-based consulting engineer BRiC Partnership suggesting steps to mitigate the problem, including replacing the underground water-distribution system and plumbing inside 15 campus buildings where the most susceptible residents live for $8 million. Jeffries said in December that plumbing replacement could cost $500 million or more; in January, she told lawmakers the price tag was $25 million to $30 million, but didn't specify the source of that estimate. She has never explained why she used estimates that at a minimum were more than four times higher than the actual number. BRiC's 2016 report, which cost $20,000, listed about a dozen ideas for a total of $17 million. The administration paid BRiC another $40,000 to update and expand its 2016 report. That update released last month indicated plumbing replacement for the entire campus would be $11 million; expanded options for the other ideas combined would cost no more than $24 million. Jeffries explained Monday that the August 2016 delivery of the BRiC report was just two months after the June completion of a $6.5 million water-treatment facility and wanted to test its effectiveness before taking any more actions. But Public Health officials had confirmed two more cases of Legionnaires' in late July, just days before BRiC's arrival on campus. ___ Contact Political Writer John O'Connor at https://twitter.com/apoconnor . His work can be found at https://apnews.com/search/john%20o'connor ___ Sign up for the AP's weekly newsletter showcasing our best reportingfrom the Midwest and Texas:http://apne.ws/2u1RMfv Claim: Rauner now plans to raze vet dorms where Legionnaires' found.
[A]: Gov. Bruce Rauner's administration announced on Monday that it plans to replace residence halls at the Quincy veterans' facility which housed victims of a Legionnaires' disease outbreak responsible for the deaths of 13 people and making dozens more ill since 2015.

[Q]: Paragraph: Such a test could initially be used to select patients for clinical trials of experimental treatments being developed to try to halt progression of Alzheimer's, the researchers said, and may one day move into routine use in doctors' clinics. "Alzheimer's begins to affect the brain many years before patients are diagnosed (and) many of our drug trials fail because by the time patients are given the drugs the brain has already been too severely affected," said Simon Lovestone of Oxford University, who led this work from King's College London. "A simple blood test could help us identify patients at a much earlier stage to take part in new trials and hopefully develop treatments," he said. Alzheimer's is the most common form of dementia, a brain-wasting disease which in 2010 was estimated to be costing the world $604 billion a year. The fatal disease affects 44 million people worldwide, with the number set to triple by 2050, the campaign group Alzheimer's Disease International says. Several big pharma firms including Roche, Eli Lilly, Merck & Co and Johnson & Johnson, are pursuing various approaches to get to the root cause of Alzheimer's and try to find treatments to halt its progression. Yet over the past 15 years, more than 100 experimental Alzheimer's drugs have failed in trial. Lovestone and other experts believe this may be because drug trials are conducted too late, in patients whose condition has already gone too far. A predictive test for use before people develop symptoms would help researchers select the right people for drug trials, and help show whether the experimental drugs are working. Previous studies have found that PET brain scans and tests of lumbar fluid can be used to predict the onset of dementia from people with a less severe condition known as mild cognitive impairment (MCI), but these tests are expensive and invasive, so scientists are keen to develop a cheaper, simpler blood test. MCI includes problems with day-to-day memory, language and attention. It can be an early sign of dementia, or a symptom of stress or anxiety. Around 10 percent of people diagnosed with MCI develop dementia within a year. Apart from regular assessments to measure memory decline, there is currently no accurate way of predicting who will or won't develop dementia. For this study, published in the journal Alzheimer's & Dementia, Lovestone's team used blood samples from 1,148 people - 476 with Alzheimer's, 220 with mild cognitive impairment and 452 elderly controls without dementia. They were analyzed for 26 proteins previously found to be linked with Alzheimer's. The team found 16 of these 26 proteins to be strongly associated with brain shrinkage in either MCI or Alzheimer's and then ran a second series of tests to see which of these could predict which patients would progress from MCI to Alzheimer's. With this second series, they found a combination of 10 proteins capable of predicting with 87 percent accuracy whether people with MCI would develop Alzheimer's disease within a year. Experts in the field welcomed the results but said they should be replicated in larger studies before an Alzheimer's blood test could be rolled out for use in doctors' clinics. "The results reported today are interesting, but as the authors point out there is still a very large amount of work remaining until a usable blood test for Alzheimer's disease becomes available," said Adrian Pini of the MRC Center for Developmental Neurobiology at King's College London. James Pickett, head of research at the Alzheimer's Society, said the research "does not mean that a blood test for dementia is just around the corner". "These 10 proteins can predict conversion to dementia with less than 90 percent accuracy, meaning one in 10 people would get an incorrect result," he said. "Accuracy would need to be improved before it could be a useful diagnostic test." Claim: Study paves the way for a blood test to predict Alzheimer's.
[A]: British scientists have identified a set of 10 proteins in the blood that can predict the onset of Alzheimer's and call this an important step towards developing a test for the incurable brain-wasting disease.

[Q]: Paragraph: The Soyuz TMA-19M capsule carrying NASA's Tim Kopra, Tim Peake of the European Space Agency and the Russian agency Roscosmos' Yuri Malenchenko touched down as scheduled at 3:15 p.m. local time (0915 GMT) about 90 miles (145 kilometers) southeast of Zhezkazgan in Kazakhstan. All descent maneuvers were performed without any hitches and the crew reported feeling fine as their ship slid off the orbit and headed down to Earth. Helicopters carrying recovery teams were circling the area as the capsule was descending slowly under a massive orange-and-white parachute. Support crew helped the trio get out of the capsule, charred by a fiery descent through the atmosphere, and placed them in reclining chairs for a quick check-up. Squinting at the sun, Peake said he felt "elated," adding that "the smells of Earth are just so strong." "I'd love some cool rain right now!" he said with a smile as he sat in scorching heat in his balky spacesuit. After a medical check-up, the crew will change their spacesuits for regular clothing and be flown separately to their respective bases. Maj. Peake, a 44-year-old former army helicopter pilot, has become a hero at home, helping rekindle an interest in space exploration. He was not the first Briton in space. Helen Sharman visited Russia's Mir space station in 1991 on a privately backed mission and several British-born American citizens flew with NASA's space shuttle program. But Peake is Britain's first publicly funded British astronaut and the first Briton to visit the International Space Station. He performed the first British space walk and was honored by Queen Elizabeth II in her annual Birthday Honors List. He excited many at home by joining the 26.2-mile (42-kilometer) London Marathon from 250 miles (400 kilometers) above the Earth, harnessed to a treadmill aboard the ISS with a simulation of the route through London's streets playing on an iPad. Peake finished the race in 3 hours and 35 minutes, a record for the fastest marathon in orbit, according to Guinness World Records. The trio spent 186 days in space since their launch in December 2015. They have conducted hundreds of experiments in biology, biotechnology, physical science and Earth science. "I'm going to miss the view definitely," Peake said after landing. NASA said the data received would help in the potential development of vaccines and could be relevant in the treatment of patients suffering from ocular diseases, such as glaucoma. For Malenchenko, it was a sixth mission, and he logged up a total of 828 days in space, the second-longest accumulated time in space after Russian Gennady Padalka. Kopra has logged up 244 days in space on two flights. NASA astronaut Jeff Williams along with Russians Oleg Skripochka and Alexey Ovchinin of Roscosmos will operate the station for three weeks until the arrival of three new crew members. Claim: 3 International Space Station astronauts land in Kazakhstan.
[A]:
An International Space Station crew including an American, a Briton and a Russian landed safely Saturday in the sun-drenched steppes of Kazakhstan.